Delayed gramicidin delivery through an intra-pipette capillary facilitates perforated patch recordings.

Autor: Kazashi K; Graduate School of Pharma-Medical Sciences, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan., Miura K; Graduate School of Pharma-Medical Sciences, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan., Ueda S; Graduate School of Pharma-Medical Sciences, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan., Utsunomiya K; Graduate School of Pharma-Medical Sciences, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan., Kiriyama M; Graduate School of Pharma-Medical Sciences, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan., Yagisawa M; Graduate School of Science and Engineering, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan., Ikeda M; Graduate School of Innovative Life Science, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan., Kano M; Department of Neurophysiology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan; International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo Institutes for Advanced Study, The University of Tokyo, Tokyo 113-0033, Japan., Tabata T; Laboratory for Biological Information Processing, Faculty of Engineering, University of Toyama, 3190 Gofuku, Toyama, Toyama 930-8555, Japan. Electronic address: ttabata@eng.u-toyama.ac.jp.

Publikováno v: Neuroscience research [Neurosci Res] 2024 Oct; Vol. 207, pp. 45-48. Date of Electronic Publication: 2024 May 11.

Definitive internal fracture fixation followed by staged free flap coverage ("fix followed by flap" protocol) for open Gustilo type IIIB fractures.

Autor: Nishida M; Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan; Orthopaedic Trauma Center, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura City, Kanagawa 247-8533, Japan., Kamekura S; Department of Orthopedic Surgery, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan; Department of Orthopaedic Surgery, Kanto Rosai Hospital, 1-1 Kizukisumiyoshi-cho, Nakahara-ku, Kawasaki, Kanagawa 211-8510, Japan. Electronic address: zoroku1118@gmail.com., Nakada I; Department of Orthopedic Surgery, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan; Department of Orthopaedic Surgery, National Rehabilitation Center for Children with Disabilities, 1-1-10 Komone, Itabashi-ku, Tokyo 173-0037, Japan., Kiriyama M; Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan; Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan., Maeda C; Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan; Department of Orthopedic Surgery, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan., Ozone E; Tertiary Emergency Medical Center, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan; Department of Orthopaedic Surgery, Chiba Aoba Municipal Hospital, 1273-2 Aoba-cho, Chuo-ku, Chiba 260-0852, Japan., Goto T; Department of Orthopedic Surgery, Tokyo Metropolitan Bokutoh Hospital, 4-23-15 Kotobashi, Sumida-ku, Tokyo 130-8575, Japan.

Publikováno v: Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association [J Orthop Sci] 2024 Apr 10. Date of Electronic Publication: 2024 Apr 10.

Optimal timing for therapeutic drug monitoring of voriconazole to prevent adverse effects in Japanese patients.

Autor: Hanai Y; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan., Ueda T; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Japan., Hamada Y; Department of Pharmacy, Tokyo Women's Medical University Hospital, Tokyo, Japan., Oda K; Department of Pharmacy, Kumamoto University Hospital, Kumamoto, Japan., Takahashi Y; Department of Pharmacy, Hyogo College of Medicine, Nishinomiya, Japan., Nakajima K; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Japan., Miyazaki Y; Department of Chemotherapy and Mycoses, National Institute of Infectious Diseases, Tokyo, Japan., Kiriyama M; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan., Uekusa S; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan., Matsuo K; Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Chiba, Japan., Matsumoto K; Division of Pharmacodynamics, Faculty of Pharmacy, Keio University, Tokyo, Japan., Kimura T; Department of Pharmacy, Juntendo University Hospital, Tokyo, Japan., Takesue Y; Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Japan.; Department of Clinical Infectious Diseases, Tokoname City Hospital, Tokoname, Japan.

Publikováno v: Mycoses [Mycoses] 2023 Dec; Vol. 66 (12), pp. 1035-1044. Date of Electronic Publication: 2023 Aug 16.

Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk.

Autor: Murakami K; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan., Harada A; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan. harada.amane@sysmex.co.jp., Toh R; Division of Evidence-Based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan. rtoh@med.kobe-u.ac.jp., Kubo T; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan., Miwa K; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan., Kim J; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan., Kiriyama M; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan., Iino T; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan., Nishikawa Y; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan., Uno SN; Central Research Laboratories, Sysmex Corporation, 4-4-4 Takatsukadai, Nishi-Ku, Kobe, 651-2271, Japan., Akatsuchi K; Sysmex R&D Center Americas, Inc., Mundelein, IL, 60060, USA., Nagao M; Division of Evidence-Based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan., Ishida T; Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan., Hirata KI; Division of Evidence-Based Laboratory Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-Cho, Chuo-Ku, Kobe, 650-0017, Japan.; Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine, Kobe, 650-0017, Japan.

Publikováno v: Scientific reports [Sci Rep] 2023 Feb 02; Vol. 13 (1), pp. 1899. Date of Electronic Publication: 2023 Feb 02.

Clinical significance of tissue inhibitor of metalloproteinase and matrix metalloproteinase mRNA expression in thymoma

Autor: Yukiue, H, Sasaki, H, Kobayashi, Y, Nakashima, Y, Moriyama, S, Yano, M, Kaji, M, Kiriyama, M, Fukai, I, Yamakawa, Y, Fujii, Y

Publikováno v: In Journal of Surgical Research February 2003 109(2):86-91